New Mechanisms in Joint Damage and Gout
Nov 08, 2013 |
Theodore Fields, MD, director, Rheumatology Faculty Practice Plan at the Hospital for Special Surgery and a professor of clinical medicine at Weill Cornell Medical College explains the new mechanisms available in gout treatment and management.
“We keep learning more about what happens in gout and how exactly the inflammatory process goes on,” Fields says. “We know a lot more than we did.”
Uric acid crystals stimulate the cells that break down bone, leading to erosions of bone in patients with gout. Fields pointed to a new study presented at ACR that is using a medicine for osteoporosis and giving it to gout patients to try and prevent some damage.